Effects of vildagliptin added to pioglitazone or glimepiride in poorly controlled type 2 diabetic patients.

Trial Profile

Effects of vildagliptin added to pioglitazone or glimepiride in poorly controlled type 2 diabetic patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 May 2014

At a glance

  • Drugs Vildagliptin (Primary) ; Glimepiride; Pioglitazone
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 13 May 2014 Results published in the Diabetic Medicine.
    • 05 Nov 2010 New trial record.
    • 29 Sep 2009 Results presented at the 45th Annual Meeting of the European Association for the Study of Diabetes.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top